Citation Impact
Citing Papers
Results of the Brazilian Osteosarcoma Treatment Group Studies III and IV: Prognostic Factors and Impact on Survival
2006
The 2016 revision of the World Health Organization classification of lymphoid neoplasms
2016 Standout
Bone Histomorphometry : Standardization of Nomenclature, Symbols, and Units
1987 Standout
Multidrug resistance in cancer: role of ATP–dependent transporters
2002 Standout
Expression of HER2/erbB-2 Correlates With Survival in Osteosarcoma
1999
MALAT1 — a paradigm for long noncoding RNA function in cancer
2013
lincRNAs: Genomics, Evolution, and Mechanisms
2013 Standout
Trabecular architecture in women and men of similar bone mass with and without vertebral fracture: II. three-dimensional histology
2000
Osteoporosis
2019 Standout
Effect of Intermittent Cyclical Etidronate Therapy on Bone Mass and Fracture Rate in Women with Postmenopausal Osteoporosis
1990
Long-term results of the co-operative German–Austrian–Swiss osteosarcoma study group’s protocol COSS-86 of intensive multidrug chemotherapy and surgery for osteosarcoma of the limbs
1998
Molecular imaging in living subjects: seeing fundamental biological processes in a new light
2003 Standout
PET as a potential tool for imaging molecular mechanisms of oncology in man
2001
Primary chemotherapy and delayed surgery for nonmetastatic osteosarcoma of the extremities. Results in 164 patients preoperatively treated with high doses of methotrexate followed by cisplatin and doxorubicin
1993
Prosthetic-Joint Infections
2004 Standout
Cell Shape, Cytoskeletal Tension, and RhoA Regulate Stem Cell Lineage Commitment
2004 Standout
Chemotherapeutic adjuvant treatment for osteosarcoma: Where do we stand?
2011
International Collaboration is Feasible in Trials for Rare Conditions: The EURAMOS Experience
2009
A comparison of methods of loco-regional chemotherapy combined with systemic chemotherapy as neo-adjuvant treatment of osteosarcoma of the extremity
2001
The emerging role of lncRNAs in cancer
2015 Standout
Guidelines for the treatment of pressure ulcers
2006
Vitamin D Deficiency
2007 Standout
Functional Classification and Experimental Dissection of Long Noncoding RNAs
2018 Standout
Double-blind controlled trial of oral clodronate in patients with bone metastases from breast cancer.
1993 Standout
The Treatment of Nonmetastatic High Grade Osteosarcoma of the Extremity: Review of the Italian Rizzoli Experience. Impact on the Future
2009
Soft-Tissue Sarcomas in Adults
2005 Standout
Bone Quality — The Material and Structural Basis of Bone Strength and Fragility
2006 Standout
Osteosarcoma treatment – Where do we stand? A state of the art review
2013 Standout
From Krebs to clinic: glutamine metabolism to cancer therapy
2016 Standout
Alveolar rhabdomyosarcomas in conditional Pax3:Fkhr mice: cooperativity of Ink4a/ARF and Trp53 loss of function
2004 StandoutNobel
Effect of Parathyroid Hormone (1-34) on Fractures and Bone Mineral Density in Postmenopausal Women with Osteoporosis
2001 Standout
Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures
1996 Standout
Osteosarcoma: The COSS Experience
2009
Ankylosing spondylitis
2007 Standout
Translation of new cancer treatments from pet dogs to humans
2008 Standout
Tumor size and prognosis in aggressively treated osteosarcoma.
1996
Predictive factors of histologic response to primary chemotherapy in osteosarcoma of the extremity: study of 272 patients preoperatively treated with high-dose methotrexate, doxorubicin, and cisplatin.
1998
U1 snRNP regulates cancer cell migration and invasion in vitro
2020 Standout
Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial
2002 Standout
Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
2009 Standout
Calcitriol Treatment Is Not Effective in Postmenopausal Osteoporosis
1989
The influence of tumor- and treatment-related factors on the development of local recurrence in osteosarcoma after adequate surgery. An analysis of 1355 patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols
2010
Loss of the abundant nuclear non-coding RNAMALAT1is compatible with life and development
2012
Age-related bone changes
1991
Delaying surgery with chemotherapy for osteosarcoma of the extremities
2004
Intra-arterial cisplatin with or without radiation in limb-sparing for canine osteosarcoma
1993
Functional imaging and the orthopaedic surgeon
2002
Truncation of the amino terminus of PTH alters its anabolic activity on bone in vivo
1996
Intermittent Cyclical Etidronate Treatment of Postmenopausal Osteoporosis
1990
Clinical Factors Associated With Calcific Aortic Valve Disease
1997 Standout
Non‐coding RNAs in cancer initiation and progression and as novel biomarkers
2011
Long Noncoding RNAs: Cellular Address Codes in Development and Disease
2013 Standout
Frailty in elderly people
2013 Standout
Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis
2009
Prevention of falls and consequent injuries in elderly people
2005 Standout
The value of FDG-PET in the detection, grading and response to therapy of soft tissue and bone sarcomas; a systematic review and meta-analysis
2003
RADIOLOGIC DIAGNOSIS AND PATHOLOGY OF THE SPONDYLOARTHROPATHIES
1998
Common Musculoskeletal Tumors of Childhood and Adolescence
1999
Controversies in the Management of Oropharynx Cancer
2008
Relative in Vitro Efficacy of the Phosphate Binders Lanthanum Carbonate and Sevelamer Hydrochloride
2007 StandoutNobel
Etidronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women
2008
Recombinant Human Parathyroid Hormone (1–34) [Teriparatide] Improves Both Cortical and Cancellous Bone Structure
2003
Pathophysiology of the Neuroregulation of Growth Hormone Secretion in Experimental Animals and the Human*
1998 Standout
Involutional Osteoporosis
1986 Standout
Peptide amidation: Production of peptide hormonesin vivo andin vitro
2001
Head and Neck Cancer
2020 Standout
Long Noncoding RNA and Cancer: A New Paradigm
2017 Standout
Vertebral fracture assessment using a semiquantitative technique
1993 Standout
MDR1 Gene Expression and Outcome in Osteosarcoma: A Prospective, Multicenter Study
2000
Age-related structural changes in trabecular and cortical bone: Cellular mechanisms and biomechanical consequences
1984
Relationships between surface, volume, and thickness of iliac trabecular bone in aging and in osteoporosis. Implications for the microanatomic and cellular mechanisms of bone loss.
1983 Standout
Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the asbmr histomorphometry nomenclature committee
1987 Standout
Combined Modality Treatment for Osteosarcoma Occurring as a Second Malignant Disease
1999
Infectious Diseases Society of America Guidelines for the Diagnosis and Treatment of Asymptomatic Bacteriuria in Adults
2005 Standout
Vitamin D Deficiency and Secondary Hyperparathyroidism in the Elderly: Consequences for Bone Loss and Fractures and Therapeutic Implications
2001 Standout
Der altersabh�ngige Verbundbau der Lendenwirbelk�rper
1980
Osteosarcoma of the Pelvis: Experience of the Cooperative Osteosarcoma Study Group
2003
Wound Microbiology and Associated Approaches to Wound Management
2001 Standout
Calcitonin
1981
Prognostic Factors in High-Grade Osteosarcoma of the Extremities or Trunk: An Analysis of 1,702 Patients Treated on Neoadjuvant Cooperative Osteosarcoma Study Group Protocols
2002 Standout
[Age-dependent compound construction of the lumbar vertebrae. An analysis of structure and form (author's transl)].
1980
Birth and Death of Bone Cells: Basic Regulatory Mechanisms and Implications for the Pathogenesis and Treatment of Osteoporosis*
2000 Standout
Changes in bone histomorphometry after long-term treatment with intermittent, cyclic etidronate for postmenopausal osteoporosis
1993
Versatile Peptide C-Terminal Functionalization via a Computationally Engineered Peptide Amidase
2016 StandoutNobel
Vitamin D and vitamin D analogues for preventing fractures in post-menopausal women and older men
2014
High‐dose methotrexate‐induced nephrotoxicity in patients with osteosarcoma
2004
Frequent detection of BRAFV 600E mutations in histiocytic and dendritic cell neoplasms
2014
Long Noncoding RNAs: Past, Present, and Future
2013 Standout
Guidelines for assessment of bone microstructure in rodents using micro–computed tomography
2010 Standout
A β-Arrestin–Biased Agonist of the Parathyroid Hormone Receptor (PTH1R) Promotes Bone Formation Independent of G Protein Activation
2009 StandoutNobel
Long Noncoding RNAs in Digestive System Malignancies: A Novel Class of Cancer Biomarkers and Therapeutic Targets?
2015
Progress and Promise of FDG-PET Imaging for Cancer Patient Management and Oncologic Drug Development
2005
Osteosarcoma: Current Treatment and a Collaborative Pathway to Success
2015 Standout
The construction and partial characterization of plasmids containing complementary DNA sequences to human calcitonin precursor polyprotein
1981 StandoutNobel
Bone metabolism and disease in chronic kidney disease
2003
Recommendations for the Outpatient Surveillance of Renal Transplant Recipients
2000
Osteosarcoma of the spine
2002
Prognostic Factors in High-Grade Osteosarcoma of the Extremities or Trunk: An Analysis of 1,702 Patients Treated on Neoadjuvant Cooperative Osteosarcoma Study Group Protocols
2002 Standout
Effect of Oral Alendronate on Bone Mineral Density and the Incidence of Fractures in Postmenopausal Osteoporosis
1995 Standout
Works of G. Delling being referenced
Prognostic significance of drug-regulated genes in high-grade osteosarcoma
2007
Architecture and distribution of cancellous bone yield vertebral fracture clues
1996
The concept and treatment of osteoporosis
1990
Results of a stimulatory therapy of low bone metabolism in osteoporosis with (1–38)hPTH and diphosphonate EHDP
1988
Effect of intraarterial versus intravenous cisplatin in addition to systemic doxorubicin, high-dose methotrexate, and ifosfamide on histologic tumor response in osteosarcoma (study COSS-86)
1990
The origin of the neoplastic stromal cell in giant cell tumor of bone1 1All figures in this article may be viewed in color on the University of Hamburg-Eppendorf web site at http://www.uke.uni-hamburg.de/zentren/klinisch-theoretische_medzin_1/osteopathologie/patho/index.html.
2003
Bone mineral density in pediatric patients after renal transplantation.
1996
Clinical, biochemical and histological results of a double-blind trial with 1,25-dihydroxyvitamin D3, estradiol and placebo in post-menopausal osteoporosis.
1984
P-glycoprotein expression in high grade central osteosarcoma and normal bone cells. An immunohistochemical study.
1997
Age-related bone changes. Histomorphometric investigation of the structure of human cancellous bone.
1973
The Action of 1,25 (OH)2D3 on Turnover Kinetic, Remodelling Surfaces and Structure of Trabecular Bone in Chronic Renal Failure
2015
The effect of calcitonin on disuse atrophy of bone in the rat
1970
Evaluation of neoadjuvant therapy response of osteogenic sarcoma using FDG PET.
1999
Autopsy-based assessment of extent and type of osteomyelitis in advanced-grade sacral decubitus ulcers: a histopathologic study.
2003
Disco-vertebral destructive lesions (So-called Andersson Lesions) associated with ankylosing spondylitis
1978
[Morphologic study of iliac crest spongiosa in patients with osteoporosis treated with combination therapy of pulsatile administration of parathyroid hormone (1-38 hPTH) and sequential addition of calcitonin nasal spray].
1990
[Quantitative analysis of bone changes during chronic hemodialysis (author's transl)].
1972